about
Treatment of X-linked hypophosphatemia with calcitriol and phosphate increases circulating fibroblast growth factor 23 concentrationsGlobal Consensus Recommendations on Prevention and Management of Nutritional RicketsA new approach for diagnosing type 1 diabetes in autoantibody-positive individuals based on prediction and natural history.Defining pathways for development of disease-modifying therapies in children with type 1 diabetes: a consensus reportRacial-ethnic disparities in management and outcomes among children with type 1 diabetes.Aggregate risk of cardiovascular disease among adolescents perinatally infected with the human immunodeficiency virus.HLA-DRB1*15:01-DQA1*01:02-DQB1*06:02 Haplotype Protects Autoantibody-Positive Relatives From Type 1 Diabetes Throughout the Stages of Disease ProgressionUnderstanding Career Success and Its Contributing Factors for Clinical and Translational Investigators.Difference in bone mass between black and white American children: attributable to body build, sex hormone levels, or bone turnover?Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D Exchange clinic registry.Commentary: Launch of a quality improvement network for evidence-based management of uncommon pediatric endocrine disorders: Turner syndrome as a prototype.Endothelial abnormalities in adolescents with type 1 diabetes: a biomarker for vascular sequelae?Incidence and characteristics of pseudoprecocious puberty because of severe primary hypothyroidism.The utility of hemoglobin A1c at diagnosis for prediction of future glycemic control in children with type 1 diabetesPubertal onset in children with perinatal HIV infection in the era of combination antiretroviral treatmentGenotype-phenotype correlation in inherited severe insulin resistance.Bone mineral density in children and adolescents with perinatal HIV infectionDiabetes-related quality of life and the demands and burdens of diabetes care among emerging adults with type 1 diabetes in the year after high school graduationThe Relationship of Worry About Hypoglycemia With Diabetes-specific and Typical Youth Behavior Among Emerging Adults With Type 1 Diabetes.Two-year clinical trial of oral alendronate versus intravenous pamidronate in children with osteogenesis imperfecta.Most youth with type 1 diabetes in the T1D Exchange Clinic Registry do not meet American Diabetes Association or International Society for Pediatric and Adolescent Diabetes clinical guidelinesContracting and monitoring relationships for adolescents with type 1 diabetes: a pilot study.Calcium requirements and metabolism in Chinese-American boys and girlsCalcium, dairy products, and energy balance in overweight adolescents: a controlled trialBody fat distribution in perinatally HIV-infected and HIV-exposed but uninfected children in the era of highly active antiretroviral therapy: outcomes from the Pediatric HIV/AIDS Cohort Study.Lower Newborn Bone Mineral Content Associated With Maternal Use of Tenofovir Disoproxil Fumarate During Pregnancy.Established and emerging biomarkers for the prediction of type 1 diabetes: a systematic review.Obesity in Youth with Type 1 Diabetes in Germany, Austria, and the United States.Metabolic abnormalities and viral replication are associated with biomarkers of vascular dysfunction in HIV-infected children.Changes in beta cell function during the proximate post-diagnosis period in persons with type 1 diabetesElevations in Circulating Methylated and Unmethylated Preproinsulin DNA in New-Onset Type 1 Diabetes.Intensified effect of adiposity on blood pressure in overweight and obese children.Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients.Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial.Bone mineral accrual and low bone mass: a pediatric perspective.Safety of tenofovir use during pregnancy: early growth outcomes in HIV-exposed uninfected infantsIntranasal Glucagon for Treatment of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes: A Randomized Crossover Noninferiority Study.Readiness for living independently among emerging adults with type 1 diabetes.Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial.Glucagon Nasal Powder: A Promising Alternative to Intramuscular Glucagon in Youth With Type 1 Diabetes
P50
Q24595718-604D4908-C4C2-4C13-874C-A5472F59E48AQ26770142-4D5DE6D9-1945-4180-ABE4-8D33AD1165DBQ27334999-B1A6D086-3FC0-4D04-8288-074473FFE014Q27687598-0AD59D53-498D-481A-8C6B-4981E909CE46Q30360577-C48D19C9-AC6F-4862-BFB7-D7FBA3FD0DBAQ30576375-827FD9BF-15D0-4D5B-9D74-653FD539C400Q30732418-20C87680-0831-4849-9561-6CB354328FC5Q30734126-271B643E-B04D-437D-B49B-E377B22A941DQ30885653-57BCC94F-9B2D-4352-BB91-939989178C53Q30956324-0B2AFE16-FB18-4FC1-9709-160E53FB390FQ33570254-6D2C3E61-FAC5-4AAD-AEDF-066499AE76C6Q33602535-5931AA75-76B4-49C6-8EEB-349ACE27B457Q33803152-8E39C321-AB08-48BB-A638-B6F6F5EF5053Q33803171-C46C1D6B-957D-483B-92EB-B35FF2AF66B6Q34083742-13C2F1DF-1D9B-4E58-B97B-BD22C63FF2C8Q34129778-286AD988-4C64-461C-8905-8D0A61C785BEQ34150394-78B21ACE-816C-446A-A5E8-0DC44E370EC5Q34205243-F2D4F8DA-393F-47AB-B129-129AC59D42DCQ34255673-CF5CEA7A-B468-499B-9E27-6D4830D46887Q34476573-90DB51EF-B7EA-4264-B9C2-97F59BCD679DQ34557730-AF57D200-CF04-4D4E-9B22-438407FC6036Q35093060-A54AD321-905B-425F-83BE-00147E260755Q35156129-D09D997A-85D3-40D4-B38E-53E37FBFF0C0Q35335470-3A6206FD-A5BE-429F-9889-5504C0745226Q35656425-03918FCA-E0A6-4CA9-BB06-DA52A67DE715Q35659264-F357B2CB-742F-4038-BF4B-ADB5F672D802Q35674747-04F6A3F1-2405-446D-BD40-47D0F7E0D7DCQ35688819-57C3CD25-CDC8-477B-AB19-00103F8F2A95Q35815450-5BDA6DBE-3C7E-4ADA-AACC-EEEEB117DBEAQ36001688-B90F8D23-8E4D-494C-902C-699ACDE4FEB8Q36186286-B3BF5362-936D-4925-BD49-187341B190ACQ36207337-28B5A869-D8FE-455B-9308-21FDA0F02979Q36216535-87EA083B-6AD4-4F89-A908-FAF2D1B38CE4Q36292592-A7055C42-27CA-4827-9175-FE4FBCB79B4AQ36324346-E6180C41-394E-47D0-82B2-05D64990A305Q36333957-E3562B17-EEFA-44D8-BA68-56AEA27DF3AEQ36490455-C6EA08B9-22A7-4F19-8576-3ED0139E9723Q36581290-723BFEF1-C599-4421-A76F-D7466081E654Q36632019-D0F35F40-6F63-4BB8-9194-7DBA9FBE5B95Q36726160-9D07C6A2-3503-43C1-8D8F-23BF79ACD452
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Linda A DiMeglio
@nl
Linda A. DiMeglio
@af
Linda A. DiMeglio
@an
Linda A. DiMeglio
@ast
Linda A. DiMeglio
@bar
Linda A. DiMeglio
@br
Linda A. DiMeglio
@ca
Linda A. DiMeglio
@co
Linda A. DiMeglio
@cs
Linda A. DiMeglio
@cy
type
label
Linda A DiMeglio
@nl
Linda A. DiMeglio
@af
Linda A. DiMeglio
@an
Linda A. DiMeglio
@ast
Linda A. DiMeglio
@bar
Linda A. DiMeglio
@br
Linda A. DiMeglio
@ca
Linda A. DiMeglio
@co
Linda A. DiMeglio
@cs
Linda A. DiMeglio
@cy
prefLabel
Linda A DiMeglio
@nl
Linda A. DiMeglio
@af
Linda A. DiMeglio
@an
Linda A. DiMeglio
@ast
Linda A. DiMeglio
@bar
Linda A. DiMeglio
@br
Linda A. DiMeglio
@ca
Linda A. DiMeglio
@co
Linda A. DiMeglio
@cs
Linda A. DiMeglio
@cy
P1153
6602134506
P1412
P21
P31
P496
0000-0002-8033-6078